Clinical Predictors of In-Hospital Mortality among Patients with Stent Thrombosis Following Primary Percutaneous

Arshad Ali1, Samiullah Shakir2, Muhammad Ibaad Siddiqui3

  • 1Department of Cardiology, Nottingham University Hospital, Nottingham, UK.

Insights

In patients experiencing stent thrombosis (ST) after primary percutaneous coronary intervention (PCI), acute hemodynamic compromise and procedural severity significantly predict in-hospital mortality. These findings highlight critical risk factors for adverse outcomes.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Clinical Research

Background:

  • Stent thrombosis (ST) is a serious complication following percutaneous coronary intervention (PCI).
  • Identifying predictors of mortality in ST patients is crucial for improving outcomes.
  • Drug-eluting stents (DES) are commonly used in primary PCI.

Purpose of the Study:

  • To identify clinical and procedural predictors of in-hospital mortality in patients with ST after primary PCI with DES.
  • To analyze the association between various patient and procedural factors and mortality risk.

Main Methods:

  • Observational cohort study conducted at a tertiary care cardiovascular hospital.
  • Consecutive adult patients with angiographically confirmed ST post-primary PCI with DES were enrolled.
  • Multivariable logistic regression was used to identify independent predictors of in-hospital mortality.

Main Results:

  • In-hospital mortality was 25.0% among 148 patients.
  • Predictors of increased mortality included temporary pacemaker use, intra-procedure slow-flow/no-reflow, advancing age, and higher heart rate.
  • Each 1 mm Hg increase in systolic blood pressure was associated with a 5% reduction in mortality.

Conclusions:

  • Acute hemodynamic compromise and procedural severity are strongly associated with in-hospital mortality in ST patients.
  • These findings underscore the importance of monitoring hemodynamic status and procedural quality.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...